Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 3;20(1):79.
doi: 10.1186/s12890-020-1090-5.

Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review

Affiliations
Review

Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review

Bas C P van Dijk et al. BMC Pulm Med. .

Abstract

Background: The Asthma Control Test (ACT) has been used to assess asthma control in both clinical trials and clinical practice. However, the relationships between ACT score and other measures of asthma impact are not fully understood. Here, we evaluate how ACT scores relate to other clinical, patient-reported, or economic asthma outcomes.

Methods: A targeted literature search of online databases and conference abstracts was performed. Data were extracted from articles reporting ACT score alongside one or more of: Asthma Control Questionnaire (ACQ) score; rescue medication use; exacerbations; lung function; health-/asthma-related quality of life (QoL); sleep quality; work and productivity; and healthcare resource use (HRU) and costs.

Results: A total of 1653 publications were identified, 74 of which were included in the final analysis. Of these, 69 studies found that improvement in ACT score was related to improvement in outcome(s), either as correlation or by association. The level of evidence for each relationship differed widely between outcomes: substantial evidence was identified for relationships between ACT score and ACQ score, lung function, and asthma-related QoL; moderate evidence was obtained for relationships between ACT score and rescue medication use, exacerbations, sleep quality, and work and productivity; limited evidence was identified for relationships between ACT score and general health-related QoL, HRU, and healthcare costs.

Conclusions: Findings of this review suggest that the ACT is an appropriate measure for overall asthma impact and support its use in clinical trial settings. GlaxoSmithKline plc. study number HO-17-18170.

Keywords: ACT; Asthma Control Test; Exacerbations; Lung function; Quality of life; Rescue medication.

PubMed Disclaimer

Conflict of interest statement

HS, LN, and AH are employees of/hold stocks in GlaxoSmithKline plc. CA is a paid employee of Pharmerit International, the vendor who conducted the research on behalf of the sponsor. BvD and JB were employees of Pharmerit International at the time of the research. Trademarks are the property of their respective owners.

Figures

Fig. 1
Fig. 1
Flow diagram of search strategy and targeted literature review approach. aArticles published before February 9th, 2017 were captured in the EMBASE, MEDLINE and EconLit database searches. bThe Cochrane database search reviewed articles published prior to January 21st, 2017. cConference abstract repositories searched were the American Thoracic Society (ATS), European Respiratory Society (ERS) and American College of Chest Physicians (ACCP) CHEST. dConference databases were searched for the last three editions of the conference in question (i.e. 2015–2017 or 2014–2016), up to January 21st, 2017. eStudies could have reported on multiple outcomes. ACT: Asthma Control Test; HRQoL: health-related quality of life; QoL: quality of life

References

    1. Global Initiative for Asthma. 2018 GINA report: global strategy for asthma management and prevention 2018. https://ginasthma.org/wp-content/uploads/2019/01/2018-GINA.pdf. Accessed 26 June 2018.
    1. National Heart, Lung, and Blood Institute. Expert panel report 3: guidelines for the diagnosis and management of asthma. 2007. https://www.nhlbi.nih.gov/files/docs/guidelines/asthgdln.pdf. Accessed 26 June 2018.
    1. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65. doi: 10.1016/j.jaci.2003.09.008. - DOI - PubMed
    1. Jia CE, Zhang HP, Lv Y, Liang R, Jiang YQ, Powell H, et al. The asthma control test and asthma control questionnaire for assessing asthma control: systematic review and meta-analysis. J Allergy Clin Immunol. 2013;131:695–703. doi: 10.1016/j.jaci.2012.08.023. - DOI - PubMed
    1. Adachi M, Goldfrad C, Jacques L, Nishimura Y. Efficacy and safety comparison: fluticasone furoate and fluticasone propionate, after step down from fluticasone furoate/vilanterol in Japanese patients with well-controlled asthma, a randomized trial. Respir Med. 2016;120:78–86. doi: 10.1016/j.rmed.2016.09.018. - DOI - PubMed